10 Best Healthcare Stocks to Buy Under $50
According to Michael Adams, the Lead Editor of Investing at Forbes, investments in healthcare stocks provide investors with consistent and steady returns because of the defensive nature of these stocks...
Protagonist Therapeutics Inc (PTGX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 5,738,973 | $166,028,489 | +1% | 0.75% |
| 2. | Biotechnology Value Fund / BVF Inc Mark Lampert | 3,755,990 | $108,660,791 | -35% | 2.98% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 2,218,868 | $64,191,851 | +72% | 0.12% |
| 4. | Point72 Asset Management Steve Cohen | 1,199,902 | $34,713,165 | -55% | 0.08% |
| 5. | Leucadia National Ian Cumming And Joseph Steinberg | 1,180,561 | $34,153,630 | -8% | 0.31% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.70 | 12,000 | Director | 15,310 | 2020-03-12 | Filing | |
| $5.70 | 8,000 | Director | 8,000 | 2019-12-03 | Filing | |
| $5.13 | 30,000 | Officer | 49,500 | 2019-12-03 | Filing | |
| $5.09 | 562 | Officer | 1,175 | 2019-12-03 | Filing | |
| $5.10 | 613 | Officer | 613 | 2019-12-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.00 | 8,000 | Director | 12,000 | 2024-06-07 | Filing | |
| $35.19 | 35,000 | Officer, Director | 515,415 | 2024-06-07 | Filing | |
| $25.11 | 1,234 | Officer | 37,163 | 2024-04-18 | Filing | |
| $28.31 | 25,000 | Officer, Director | 549,590 | 2024-04-01 | Filing | |
| $31.62 | 30,000 | Officer, Director | 574,590 | 2024-03-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,543,902 | $127,121,672 | 0% | |
| 2. | 5,315,514 | $121,884,736 | 1.9% | |
| 3. | 3,153,916 | $72,319,294 | 0% | |
| 4. | 2,729,929 | $62,597,272 | 0% | |
| 5. | 2,449,183 | $56,159,766 | 1.28% |
News See All
Top 5 Stock Picks of Farallon Capital
In this article, we discuss the top 5 stock picks of Farallon Capital.
5 Stocks Under $30 to Buy Today According to Billionaire Steven Cohen
In this piece, we will look at the ten stocks under $30 to buy today according to billionaire Steven Cohen.
These 5 Stocks Are Crashing Today
In this article, we take a look at five stocks that are crashing today.
Protagonist Therapeutics, Inc. (PTGX) Fell Out Of Favor With Hedge Funds
In this article we will check out the progression of hedge fund sentiment towards Protagonist Therapeutics, Inc. (NASDAQ:PTGX) and determine whether it is a good investment right now.
5 Small-Cap Stocks to Buy According to Billionaire Steve Cohen
In this article, we discuss the 5 small-cap stocks to buy according to billionaire Steve Cohen.
5 Best Biotech Stocks to Buy According to Mark Lampert's Biotechnology Value Fund
In this article, we discuss the 5 best biotech stocks to buy according to Mark Lampert.
5 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
Below is the list of 5 pharma stocks to buy according to Mark Lampert’s Biotechnology Value Fund.
Hedge Funds Are Crazy About Protagonist Therapeutics, Inc. (PTGX)
At Insider Monkey, we pore over the filings of nearly 873 top investment firms every quarter, a process we have now completed for the latest reporting period.
Billionaire Hedge Funds
